[go: up one dir, main page]

GB0403779D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB0403779D0
GB0403779D0 GB0403779A GB0403779A GB0403779D0 GB 0403779 D0 GB0403779 D0 GB 0403779D0 GB 0403779 A GB0403779 A GB 0403779A GB 0403779 A GB0403779 A GB 0403779A GB 0403779 D0 GB0403779 D0 GB 0403779D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0403779A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0403779A priority Critical patent/GB0403779D0/en
Publication of GB0403779D0 publication Critical patent/GB0403779D0/en
Priority to ES05717730T priority patent/ES2329915T3/en
Priority to KR1020067019280A priority patent/KR20060131906A/en
Priority to US10/588,294 priority patent/US20090149463A1/en
Priority to CN2005800049765A priority patent/CN1918129B/en
Priority to DE602005016082T priority patent/DE602005016082D1/en
Priority to HK07102485.1A priority patent/HK1095329B/en
Priority to BRPI0507786-9A priority patent/BRPI0507786A/en
Priority to EP05717730A priority patent/EP1718617B1/en
Priority to AT05717730T priority patent/ATE440085T1/en
Priority to CA2555331A priority patent/CA2555331C/en
Priority to AU2005214130A priority patent/AU2005214130B2/en
Priority to RU2006130683/04A priority patent/RU2375349C2/en
Priority to JP2006553649A priority patent/JP4208925B2/en
Priority to PCT/GB2005/000534 priority patent/WO2005080343A2/en
Priority to UY28752A priority patent/UY28752A1/en
Priority to ARP050100566A priority patent/AR047683A1/en
Priority to TW094104925A priority patent/TW200531689A/en
Priority to IL177218A priority patent/IL177218A0/en
Priority to ZA200606563A priority patent/ZA200606563B/en
Priority to NO20063787A priority patent/NO20063787L/en
Ceased legal-status Critical Current

Links

GB0403779A 2004-02-20 2004-02-20 Therapeutic agents Ceased GB0403779D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GB0403779A GB0403779D0 (en) 2004-02-20 2004-02-20 Therapeutic agents
PCT/GB2005/000534 WO2005080343A2 (en) 2004-02-20 2005-02-16 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
CA2555331A CA2555331C (en) 2004-02-20 2005-02-16 Therapeutic agents
RU2006130683/04A RU2375349C2 (en) 2004-02-20 2005-02-16 Derivatives of 3-substituted 1,5-diphenylpyrazole effective as cb1 modulators
US10/588,294 US20090149463A1 (en) 2004-02-20 2005-02-16 Therapeutic agents
CN2005800049765A CN1918129B (en) 2004-02-20 2005-02-16 therapeutic agent
DE602005016082T DE602005016082D1 (en) 2004-02-20 2005-02-16 3-SUBSTITUTED 1,5-DIPHENYLPYRAZOL DERIVATIVES SUITABLE AS CB1 MODULATORS
HK07102485.1A HK1095329B (en) 2004-02-20 2005-02-16 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
BRPI0507786-9A BRPI0507786A (en) 2004-02-20 2005-02-16 compound and pharmaceutically acceptable salts thereof, pharmaceutical formulation, use of a compound, method of treating a disease, and process for preparing compounds
EP05717730A EP1718617B1 (en) 2004-02-20 2005-02-16 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
AT05717730T ATE440085T1 (en) 2004-02-20 2005-02-16 3-SUBSTITUTED 1,5-DIPHENYLPYRAZOLE DERIVATIVES SUITABLE AS CB1 MODULATORS
ES05717730T ES2329915T3 (en) 2004-02-20 2005-02-16 DERIVATIVES OF 1,5-DIFENYLPIRAZOL 3-USEFUL SUBSTITUTES AS CB1 MODULATORS
AU2005214130A AU2005214130B2 (en) 2004-02-20 2005-02-16 3-substituted 1,5-diphenylpyrazole derivatives useful as CB1 modulators
KR1020067019280A KR20060131906A (en) 2004-02-20 2005-02-16 3-Substituted 1,5-diphenylpyrazole Derivatives Useful as Ck1 Modulators
JP2006553649A JP4208925B2 (en) 2004-02-20 2005-02-16 Remedy
ARP050100566A AR047683A1 (en) 2004-02-20 2005-02-17 PIRAZOLES FOR THE TREATMENT OF OBESITY AND PSYCHIATRIC DISORDERS
UY28752A UY28752A1 (en) 2004-02-20 2005-02-17 THERAPEUTIC AGENTS
TW094104925A TW200531689A (en) 2004-02-20 2005-02-18 Therapeutic agents
IL177218A IL177218A0 (en) 2004-02-20 2006-08-01 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
ZA200606563A ZA200606563B (en) 2004-02-20 2006-08-07 3-Substituted 1,5-diphenylpyrazole derivatives useful as CB1 Modulators
NO20063787A NO20063787L (en) 2004-02-20 2006-08-24 Therapeutic preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0403779A GB0403779D0 (en) 2004-02-20 2004-02-20 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB0403779D0 true GB0403779D0 (en) 2004-03-24

Family

ID=32040067

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0403779A Ceased GB0403779D0 (en) 2004-02-20 2004-02-20 Therapeutic agents

Country Status (3)

Country Link
CN (1) CN1918129B (en)
GB (1) GB0403779D0 (en)
ZA (1) ZA200606563B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024092205A1 (en) * 2022-10-27 2024-05-02 The Trustees Of Indiana University Inhibition of ship1 as a therapeutic strategy for the treatment of alzheimer's disease

Also Published As

Publication number Publication date
ZA200606563B (en) 2008-10-29
CN1918129B (en) 2011-06-15
CN1918129A (en) 2007-02-21

Similar Documents

Publication Publication Date Title
EP1730148A4 (en) Aminobenzoxazoles as therapeutic agents
GB0419850D0 (en) Therapeutic agents
GB0416396D0 (en) Therapeutic agents
GB0506147D0 (en) Therapeutic agents
GB0403780D0 (en) Therapeutic agents
GB0505437D0 (en) Therapeutic agents
GB0505725D0 (en) Therapeutic agents
GB0423103D0 (en) Therapeutic agents
GB0419192D0 (en) Therapeutic agents
GB0514738D0 (en) Therapeutic agents
GB0516661D0 (en) Therapeutic agents
GB0417939D0 (en) Therapeutic agents
GB0400193D0 (en) Therapeutic agents
GB0427701D0 (en) Therapeutic agents
GB0402918D0 (en) Therapeutic agents
GB0428075D0 (en) Therapeutic agents
GB0403779D0 (en) Therapeutic agents
GB0416934D0 (en) Therapeutic agents
GB0400196D0 (en) Therapeutic agents
GB0425207D0 (en) Therapeutic agents
GB0425209D0 (en) Therapeutic agents
GB0420781D0 (en) Therapeutic agents
GB0422284D0 (en) Therapeutic agents
GB0410855D0 (en) Therapeutic agents
GB0408348D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)